Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print

Pall To Acquire ATMI



By Gil Roth



Published December 23, 2013
Related Searches: Pharma contractpharma.com Biopharma contractpharma
Pall Corp. will acquire the ATMI LifeSciences business of ATMI, Inc. for $185 million. ATMI LifeSciences makes and sells single-use bioprocess systems and consumables for the pharma and biopharma industries. The deal is expected to close by the end of Pall’s third quarter, which ends in April 2014. For the balance of fiscal 2014, Pall expects the acquisition to add $20 to $30 million in revenue.
 
“This acquisition immediately strengthens our offering and broadens our already extensive portfolio of advanced solutions for biopharmaceutical customers,” said Larry Kingsley, Pall’s chairman and chief executive officer.
 
Doug Neugold, ATMI’s chief executive officer, said, “We are very happy to have Pall as the new owner of this business, and believe the fit and their capabilities will accelerate its growth and provide great support to our customers.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On